The accessibility and equitable distribution of GLP-1 receptor agonists remain challenging with high costs, limited insurance coverage, and geographic disparities creating barriers to access, particularly affecting those in healthcare deserts or demographics with lower healthcare outcomes (Azizi et al., 2024
Shaharyar Khan, PhD, Chief Scientific Officer Number Of Employees: ~27 Stage: Private, Series B2 Financial Snapshot: Has raised $224M total across funding rounds, including a $132M Series B Notable Investors: RA Capital Management
Extracellular matrix proteins, including fibronectin and tenascin-C, accumulate at higher rates in BPC-157-exposed tendon tissue, creating a scaffold favorable for organized collagen deposition
Ozempic (semaglutida 1 mg semanal, indicacin DM2) es probablemente el frmaco ms demandado de los ltimos 5 aos en Colombia, y tambin uno de los ms difciles de conseguir de manera consistente